Terms: = Thyroid cancer AND MYC, c-Myc, 4609, ENSG00000136997 AND Clinical Outcome
5 results:
1. mycBP2 expression correlated with inflammatory cell infiltration and prognosis immunotherapy in thyroid cancer patients.
Wang G; Miao C; Mo L; Kahlert UD; Wu J; Ou M; Huang R; Feng R; Pang W; Shi W
Front Immunol; 2022; 13():1048503. PubMed ID: 36582246
[TBL] [Abstract] [Full Text] [Related]
2. Steroid receptor-associated and regulated protein is a biomarker in predicting the clinical outcome and treatment response in malignancies.
Naderi A
Cancer Rep (Hoboken); 2020 Oct; 3(5):e1267. PubMed ID: 32706923
[TBL] [Abstract] [Full Text] [Related]
3. PAK2-c-myc-PKM2 axis plays an essential role in head and neck oncogenesis via regulating Warburg effect.
Gupta A; Ajith A; Singh S; Panday RK; Samaiya A; Shukla S
Cell Death Dis; 2018 Aug; 9(8):825. PubMed ID: 30068946
[TBL] [Abstract] [Full Text] [Related]
4. Molecular genotyping of medullary thyroid carcinoma can predict tumor recurrence.
Sheikh HA; Tometsko M; Niehouse L; Aldeeb D; Swalsky P; Finkelstein S; Barnes EL; Hunt JL
Am J Surg Pathol; 2004 Jan; 28(1):101-6. PubMed ID: 14707871
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic value of N-myc immunoreactivity in medullary thyroid carcinoma.
Roncalli M; Viale G; Grimelius L; Johansson H; Wilander E; Alfano RM; Springall D; Battezzati PM; Polak JM; Coggi G
Cancer; 1994 Jul; 74(1):134-41. PubMed ID: 7911734
[TBL] [Abstract] [Full Text] [Related]
